Sands Capital Ventures, LLC

Investment Portfolio & 13F Holdings Analysis

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
20
Total Value
408897024
Accession Number
0001846444-25-000005
Form Type
13F-HR
Manager Name
Sands-Capital-Ventures
Data Enrichment
95% identified
19 identified1 unidentified

Holdings

20 positions
Manager:
Search and click to pin securities to the top
Klaviyo, Inc.
Shares:3.4M
Value:$104.2M
Nu Holdings Ltd.
Shares:7.2M
Value:$73.4M
DoorDash, Inc.
Shares:380.7K
Value:$69.6M
08659B102
Shares:3.1M
Value:$38.0M
Inhibikase Therapeutics, Inc.
Shares:10.9M
Value:$24.0M
Coupang, Inc.
Shares:843.5K
Value:$18.5M
monday.com Ltd.
Shares:49.9K
Value:$12.1M
Datadog, Inc.
Shares:117.9K
Value:$11.7M
Samsara Inc.
Shares:253.4K
Value:$9.7M
Tarsus Pharmaceuticals, Inc.
Shares:170.0K
Value:$8.7M
Toast, Inc.
Shares:210.6K
Value:$7.0M
CrowdStrike Holdings, Inc.
Shares:15.6K
Value:$5.5M
Acrivon Therapeutics, Inc.
Shares:2.1M
Value:$4.3M
10x Genomics, Inc.
Shares:481.8K
Value:$4.2M
UiPath, Inc.
Shares:395.9K
Value:$4.1M
Snowflake Inc.
Shares:26.8K
Value:$3.9M
Acumen Pharmaceuticals, Inc.
Shares:3.4M
Value:$3.8M
BioAge Labs, Inc.
Shares:786.4K
Value:$3.0M
Candel Therapeutics, Inc.
Shares:405.8K
Value:$2.3M
Taysha Gene Therapies, Inc.
Shares:724.9K
Value:$1.0M